Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma have?
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma has 502 citations in the OpenAlex counts ScholarIQ stores.
When was Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma published?
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma has 2017 year in the ScholarIQ index.
What is the open-access status of Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma?
Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma has bronze oa status in the ScholarIQ index.
What is the DOI of Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma?
The DOI for Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma is on the source record.
What is the PMID of Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma?
The PMID for Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma is on the source record.
What is the OpenAlex record for Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma?
The OpenAlex for Inhibition of B Cell Receptor Signaling by Ibrutinib in Primary CNS Lymphoma is on the source record.